INTERNATIONAL PATENT: SHANGHAI XINXI PHARMACEUTICAL SCIENCE & TECHNOLOGY FIRM, 上海辛禧医药科技事务所 FILES APPLICATION FOR "CO-AGONIST TARGETING GLP-1R, GIPR AND GCGR"

GENEVA, Dec. 8 -- SHANGHAI XINXI PHARMACEUTICAL SCIENCE & TECHNOLOGY FIRM (9D, No. 288 Xiepu RoadPudong New Area, Shanghai 200135), 上海辛禧医药科技事务所 (中国上海市浦东新区歇浦路288号9D) filed a patent application (PCT/CN2025/085455) for "CO-AGONIST TARGETING GLP-1R, GIPR AND GCGR" on Mar 27, 2025. With publication no. WO/2025/246595, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(...